The study began in 2023 with ethics approvals being granted in Australia, Canada, the United Kingdom and the United States of America.
Stages 1 and 2 have now been completed and Stage 3 will commence soon.
The study began in 2023 with ethics approvals being granted in Australia, Canada, the United Kingdom and the United States of America.
Stages 1 and 2 have now been completed and Stage 3 will commence soon.
